National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 11) (PB 117 of 2020) (Cth)

PB 117 of 2020

National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 11)

I, Thea Connolly, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following determination.

Dated     26 November 2020               

THEA CONNOLLY

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010)                 2

1  Name

This instrument is the National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 11).

This instrument may also be cited as PB 117 of 2020.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 December 2020.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 85AB(1) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010)

1  Schedule 1, after item dealing with Amantadine

Omit:

Ambrisentan

2  Schedule 1, after item dealing with Armodafinil

Omit:

Arsenic

3  Schedule 1, after item dealing with Mepolizumab

Omit:

Mercaptopurine

4  Schedule 1, after item dealing with Ponatinib 

Omit:

Posaconazole

5  Schedule 1, after item dealing with Protein formula with carbohydrate, fat, vitamins and minerals 

Insert:

Protein formula with vitamins and minerals, and low in potassium, phosphorus, calcium, chloride and vitamin A

6  Schedule 2 after item dealing with Alprazolam

Insert:

Ambrisentan

7  Schedule 2, after item dealing Aripiprazole

Insert:

Arsenic

8  Schedule 2, after item dealing Memantine

Insert:

Mercaptopurine

9  Schedule 2, after item dealing Polyvinyl alcohol

Insert:

Posaconazole